plantamajoside and Multiple-Organ-Failure

plantamajoside has been researched along with Multiple-Organ-Failure* in 1 studies

Other Studies

1 other study(ies) available for plantamajoside and Multiple-Organ-Failure

ArticleYear
Plantamajoside alleviates acute sepsis-induced organ dysfunction through inhibiting the TRAF6/NF-κB axis.
    Pharmaceutical biology, 2023, Volume: 61, Issue:1

    Plantamajoside (PMS) possesses rich pharmacological characteristics that have been applied to remedy dozens of diseases. However, the understanding of PMS in sepsis remains insufficient.. Role of PMS in sepsis-regulated organ dysfunction and potential mechanisms were investigated.. All doses of PMS enhanced the survival rates in the sepsis-induced mouse model. PMS remitted sepsis-mediated lung, liver and heart injury through prohibiting MPO/BALF (70.4%/85.6%), AST/ALT (74.7%/62.7%) and CK-MB/CK (62.3%/68.9%) levels. Moreover, the apoptosis index (lung 61.9%, liver 50.2%, heart 55.7% reduction) and IL-6/TNF-α/IL-1β levels were suppressed by PMS. Furthermore, PMS lowered TRAF6 and p-NF-κB p65 levels, whereas TRAF6 overexpression reversed the protective influences of PMS in organ injury, apoptosis and inflammation triggered by sepsis.. PMS suppressed sepsis-induced organ dysfunction by regulating the TRAF6/NF-κB axis, and PMS treatment may be considered as a novel strategy for sepsis-caused damage in future.

    Topics: Animals; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Multiple Organ Failure; NF-kappa B; Sepsis; TNF Receptor-Associated Factor 6; Tumor Necrosis Factor-alpha

2023